Medtronic Kanghui and Huashan Hospital Announce Strategic Collaboration to Co-Build an Industry-Medicine Integration Innovation Platform in Neuroscience

Accelerate the Clinical Innovation and Transformation of Neuroscience in China to Promote High-Quality Development of the Discipline and Industry

Changzhou, JiangsuJuly 13, 2023PR Newswire -- Today, Medtronic Kanghui and Huashan Hospital Affiliated to Fudan University ("Huashan Hospital" for short) signed a strategic cooperation agreement. The two parties will jointly build the "Neuroscience Industry-Medicine Integration Innovation Platform," and at the same time, unveil the Changzhou Technology Transformation Center under the platform.The cooperation between the two parties will take clinical needs as the starting point for innovation, comprehensively deploy the construction of a neuroscience innovation ecosystem, and lead the high-quality development of neuroscience in China.

Medtronic Kanghui Signs Strategic Cooperation Agreement with Huashan Hospital Affiliated to Fudan University

Changzhou Technology Transfer Center of the Integrated Innovation Platform for Industry and Medicine Successfully Unveiled

With the acceleration of social aging and significant changes in public living habits, the number of patients with neurological disorders in China continues to rise, and their demand for high-quality medical services is becoming increasingly prominent. At the same time, under the guidance of the "14th Five-Year Plan" and the "Healthy China 2030" initiative, the healthcare industry is comprehensively implementing an innovation-driven strategy, and neuroscience has entered a critical period of development opportunities. The further enhancement of clinical standards in neuroscience and local innovation capabilities is of great significance for building an innovative value chain in China’s neuroscience and brain science sectors, improving people's health and well-being, and achieving the goals of Healthy China.

Focusing on the vast unmet clinical needs, and integrating emerging new concepts, technologies, and therapies,Actively promoting the "integration of industry and medicine" and "medical-engineering transformation" in neuroscience will further boost high-quality development in the discipline, bring more health benefits to patients, and help Chinese neuroscience integrate into the global healthcare system at a higher level of innovation.

Medtronic Kanghui and Huashan Hospital will establish a "Neuroscience Industry-Medicine Integration Innovation Platform" with a dumbbell-shaped dual-center layout, oriented towards patient needs, sharing technical achievements and resource services.Huashan Hospital, as a clinical research and development center for neuroscience, focuses on demand-oriented clinical research, academic exchange for innovative transformation, patent applications for research results, and more. The Changzhou Technology Transformation Center will rely on the four key functions of Medtronic Kanghui's Changzhou Science and Technology Park: the Clinical Customer Center, Intelligent Manufacturing Center, Excellence in R&D Center, and Innovation Incubation Center. Leveraging world-class leading R&D and production technologies, the center will complete the validation and incubation of innovative products, accelerate the commercialization process, and achieve clinical implementation and industrialization of innovations to address unmet patient needs in China through local innovation. In the future, with the continuous deepening of cooperation content and the ongoing expansion of collaboration areas, there is potential to bring locally developed innovations to the international stage, benefiting a broader global patient population.

This time, Huashan Hospital has joined hands with Medtronic Kanghui to jointly build an industry-medical integration and innovation platform, which is truly a powerful collaboration between the clinical and industrial fields. For decades, Huashan Hospital has been leading the development of neuroscience in China by taking the lead in formulating guidelines and consensus related to the discipline, organizing academic conferences, establishing basic laboratories, etc., effectively promoting the construction and rapid development of neurology medicine across China. In recent years, as the main hospital of the National Neurological Disease Medical Center, Huashan Hospital has been actively playing a leading role, continuously making breakthroughs in the transformation of scientific and technological achievements, drug development, surgical instrument research, and basic research.

Medtronic is a global leader in healthcare innovation, with extensive professional expertise and abundant resources within its innovative ecosystem. Medtronic China's Orthopedics and Neurosurgery Business Group operates two major brands in China: Medtronic and Kanghui. By continuously introducing advanced technologies, strengthening local R&D, high-end manufacturing, innovation incubation, and providing specialized education and services, the group offers comprehensive localized capabilities. It provides Chinese patients and doctors with diversified products and solutions while empowering the local innovation value chain.

In the future, the two parties will make full use of their respective advantageous resources, focusing on clinical needs such as cerebrovascular diseases, intracranial space-occupying diseases, functional neurology, craniocerebral trauma, and neurocritical care. They will form multi-channel resource linkages in intelligent devices, new technologies, and new materials such as precision navigation, artificial intelligence, and brain-computer interfaces, jointly promoting innovation, advancing transformation, and building an ecosystem to enhance efficiency and inject new vitality into the development of China's neuroscience field.

"The development of neuroscience in China has a history of less than a hundred years, but the achievements made in the field of neurological diseases are encouraging."Professor Mao Ying, President of Huashan HospitalIn the speech, it was stated: "We are delighted to join hands with Medtronic to embrace cutting-edge technology, inspire clinical diagnostic thinking, cultivate higher-value neuroscience and medical talents, and push the development of China's neuroscience industry into a new journey."

"Accelerating the R&D and implementation of innovative products, and assisting in the incubation and commercialization of innovative projects are Medtronic's unshirkable responsibilities. Collaborating with Huashan Hospital to jointly build a neuroscience industry-medical integration innovation platform represents another comprehensive strategic layout by Medtronic in the innovation value chain, and will also establish an innovative benchmark for the 'industry-university-research-medical' collaborative model."Yu Jing, Vice President of Medtronic and General Manager of Medtronic China Orthopedics and Neurosurgery Business Group"In the future, we will continue to strengthen local capacity building, optimize the co-creation platform for industry, academia, research, and medicine, promote the creation of a local innovation ecosystem, and work hand-in-hand with the industry to provide Chinese patients with more efficient, safe, and personalized medical solutions. This will help enhance the value chain of local innovation in China’s neurosciences, promoting high-quality development in both the discipline and the industry!"